Gene · 5345
Papers4,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease. | PLoS One | 2022 | 35045102 | PubTator, text mining | PubMed |
| Multiphysics Modelling and Simulation of Thrombolysis via Activated Platelet-Targeted Nanomedicine. | Pharm Res | 2022 | 35044591 | PubTator, text mining | PubMed |
| Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism. | Clin Appl Thromb Hemost | 2022 | 35043658 | PubTator, text mining | PubMed |
| Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN study. | J Thromb Haemost | 2022 | 35038781 | PubTator, text mining | PubMed |
| Coagulation profile of human COVID-19 convalescent plasma. | Sci Rep | 2022 | 35022488 | PubTator, text mining | PubMed |
| Counting the Hidden Costs of Male Reproductive Health. | World J Mens Health | 2022 | 35021301 | PubTator, text mining | PubMed |
| Periodontal disease prevalence, extent, and risk associations in untreated individuals. | Clin Exp Dent Res | 2022 | 35015383 | PubTator, text mining | PubMed |
| Co-Expression Analysis of microRNAs and Proteins in Brain of Alzheimer's Disease Patients. | Cells | 2022 | 35011725 | PubTator, text mining | PubMed |
| Microscale structural changes of individual fibrin fibers during fibrinolysis. | Acta Biomater | 2022 | 35007782 | PubTator, text mining | PubMed |
| Comprehensive coagulation and fibrinolytic potential in the acute phase of pediatric patients with idiopathic nephrotic syndrome evaluated by whole blood-based rotational thromboelastometry. | Pediatr Nephrol | 2022 | 34997323 | PubTator, text mining | PubMed |
What Laboratory Tests and Physiologic Triggers Should Guide the Decision to Administer a Platelet or Plasma Transfusion in Critically Ill Children and What Product Attributes Are Optimal to Guide Specific Product Selection? From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding. | Pediatr Crit Care Med | 2022 | 34989701 | PubTator, text mining | PubMed |
| Clinical validation of the use of prototype software for automatic cartilage segmentation to quantify knee cartilage in volunteers. | BMC Musculoskelet Disord | 2022 | 34980107 | PubTator, text mining | PubMed |
| Novel human liver-tropic AAV variants define transferable domains that markedly enhance the human tropism of AAV7 and AAV8. | Mol Ther Methods Clin Dev | 2022 | 34977275 | PubTator, text mining | PubMed |
| Factor VII activating protease (FSAP) is not essential in the pathophysiology of angioedema in patients with C1 inhibitor deficiency. | Mol Immunol | 2022 | 34973499 | PubTator, text mining | PubMed |
| Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? | Thromb Res | 2022 | 34953317 | PubTator, text mining | PubMed |
| Characterization and first-in-human clinical dose-escalation safety evaluation of a next-gen human freeze-dried plasma. | Transfusion | 2022 | 34951486 | PubTator, text mining | PubMed |
| Crise sanitaire : quelles opportunités pour la recherche clinique sur le médicament ? | Therapie | 2022 | 34924206 | PubTator, text mining | PubMed |
| Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower-leg injury or knee arthroscopy. | J Thromb Haemost | 2022 | 34919779 | PubTator, text mining | PubMed |
| Paediatric Hypertension in Africa: A Systematic Review and Meta-Analysis. | EClinicalMedicine | 2022 | 34917909 | PubTator, text mining | PubMed |
| Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada. | Transfusion | 2022 | 34907536 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5345/papers?page=41